Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3482303)

Published in Psychopharmacology (Berl) on June 06, 2012

Authors

Thomas C Jhou1, Sheng-Ping Xu, Mary R Lee, Courtney L Gallen, Satoshi Ikemoto

Author Affiliations

1: Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA. tomjhou@gmail.com

Articles citing this

Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways. J Neurosci (2013) 1.73

Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal. J Neurosci (2015) 1.47

Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci (2012) 1.42

Spatiotemporal control of opioid signaling and behavior. Neuron (2015) 1.32

Direct bidirectional μ-opioid control of midbrain dopamine neurons. J Neurosci (2014) 0.93

Basal ganglia circuit loops, dopamine and motivation: A review and enquiry. Behav Brain Res (2015) 0.90

Neurocircuitry of drug reward. Neuropharmacology (2013) 0.90

Sources of input to the rostromedial tegmental nucleus, ventral tegmental area, and lateral habenula compared: A study in rat. J Comp Neurol (2015) 0.86

Ablation of μ opioid receptor-expressing GABA neurons in rostromedial tegmental nucleus increases ethanol consumption and regulates ethanol-related behaviors. Neuropharmacology (2016) 0.86

Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental area. Neuropsychopharmacology (2014) 0.82

Response of the Tail of the Ventral Tegmental Area to Aversive Stimuli. Neuropsychopharmacology (2016) 0.78

Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum. Biol Psychiatry (2015) 0.78

Pharmacological Manipulation of the Rostromedial Tegmental Nucleus Changes Voluntary and Operant Ethanol Self-Administration in Rats. Alcohol Clin Exp Res (2016) 0.77

Supplemental morphine infusion into the posterior ventral tegmentum extends the satiating effects of self-administered intravenous heroin. Pharmacol Biochem Behav (2015) 0.76

Role for the Rostromedial Tegmental Nucleus in Signaling the Aversive Properties of Alcohol. Alcohol Clin Exp Res (2016) 0.75

Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area. J Neurosci (2016) 0.75

Learning From One's Mistakes: A Dual Role for the Rostromedial Tegmental Nucleus in the Encoding and Expression of Punished Reward Seeking. Biol Psychiatry (2016) 0.75

Muscarinic cholinergic receptor antagonists in the VTA and RMTg have opposite effects on morphine-induced locomotion in mice. Behav Brain Res (2017) 0.75

The Effects of Perinatal Oxycodone Exposure on Behavioral Outcome in a Rodent Model. Front Pediatr (2017) 0.75

Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders. Curr Treat Options Psychiatry (2017) 0.75

Articles cited by this

A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42

Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev (2007) 6.36

The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain (1977) 5.45

Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci (1992) 5.27

Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 4.87

The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron (2009) 4.12

The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol (2009) 2.83

Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol (2009) 2.47

Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46

Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol (1994) 2.33

Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates. J Neurosci (2011) 2.19

Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther (1993) 2.01

Afferents to the ventrolateral preoptic nucleus. J Neurosci (2002) 1.86

Orexin (hypocretin) neurons contain dynorphin. J Neurosci (2001) 1.84

Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77

Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res (1976) 1.66

The inhibitory influence of the lateral habenula on midbrain dopamine cells: ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J Comp Neurol (2011) 1.59

Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol (1996) 1.50

The role of dopamine in the nucleus accumbens in analgesia. Life Sci (1999) 1.44

Regional differences within the rat ventral tegmental area for muscimol self-infusions. Pharmacol Biochem Behav (1998) 1.43

Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci (2011) 1.41

Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol (1999) 1.36

Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci (1994) 1.35

Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J Neurosci (2002) 1.35

The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci (1997) 1.33

Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology (2010) 1.29

Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci U S A (2011) 1.23

Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther (1993) 1.18

A head-attachable device for injecting nanoliter volumes of drug solutions into brain sites of freely moving rats. J Neurosci Methods (2001) 1.15

Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology (2011) 1.14

Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci (1997) 1.14

Heroin reward is dependent on a dopaminergic substrate. Life Sci (1981) 1.10

Neural mechanisms of freezing and passive aversive behaviors. J Comp Neurol (2005) 1.00

Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus. Brain Res (2008) 0.97

Different neural systems mediate morphine reward and its spontaneous withdrawal aversion. Eur J Neurosci (2009) 0.93

The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system. Basal Ganglia (2011) 0.90

Mesopontine rostromedial tegmental nucleus neurons projecting to the dorsal raphe and pedunculopontine tegmental nucleus: psychostimulant-elicited Fos expression and collateralization. Brain Struct Funct (2011) 0.90

Morphine injected into the habenula and dorsal posteromedial thalamus produces analgesia in the formalin test. Brain Res (1985) 0.89

Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology (2006) 0.88

Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther (1993) 0.88

Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology (Berl) (2002) 0.87

Dopamine receptor subtypes and formalin test analgesia. Pharmacol Biochem Behav (1991) 0.87

Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience (1994) 0.86

Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat. Neuropharmacology (1989) 0.85

Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther (1998) 0.85

Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat. J Pharmacol Exp Ther (2004) 0.84

Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray. Behav Brain Res (1998) 0.82

A five-minute, but not a fifteen-minute, conditioning trial duration induces conditioned place preference for cocaine administration into the olfactory tubercle. Synapse (2005) 0.81

3-O-acetylmorphine-6-O-sulfate: a potent, centrally acting morphine derivative. Pharmacol Biochem Behav (1996) 0.80

Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. Bioorg Med Chem (2009) 0.79

Articles by these authors

Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways. J Neurosci (2013) 1.73

Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J Neurosci (2002) 1.35

Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci (2014) 1.30

Two brain sites for cannabinoid reward. J Neurosci (2006) 1.27

Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology (2008) 1.18

Amphetamine administration into the ventral striatum facilitates behavioral interaction with unconditioned visual signals in rats. PLoS One (2010) 1.05

The midbrain raphe nuclei mediate primary reinforcement via GABA(A) receptors. Eur J Neurosci (2007) 1.03

Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle. Psychopharmacology (Berl) (2008) 0.91

The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats. Psychopharmacology (Berl) (2010) 0.88

Service dog training program for treatment of posttraumatic stress in service members. US Army Med Dep J (2012) 0.84

Oxytocin selectively increases perceptions of harm for victims but not the desire to punish offenders of criminal offenses. Soc Cogn Affect Neurosci (2012) 0.84

Enhancing participant safety through electronically generated medication order sets in a clinical research environment: a medical informatics initiative. Clin Transl Sci (2010) 0.83

Synergistic interaction between caloric restriction and amphetamine in food-unrelated approach behavior of rats. Psychopharmacology (Berl) (2013) 0.82

Administration of the GABAA receptor antagonist picrotoxin into rat supramammillary nucleus induces c-Fos in reward-related brain structures. Supramammillary picrotoxin and c-Fos expression. BMC Neurosci (2010) 0.81

Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications. Ann N Y Acad Sci (2013) 0.81

Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol (2011) 0.81

Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans. PLoS One (2011) 0.81

Rewarding and incentive motivational effects of excitatory amino acid receptor antagonists into the median raphe and adjacent regions of the rat. Psychopharmacology (Berl) (2012) 0.80

Progress of pharmacological studies on alkaloids from Apocynaceae. J Asian Nat Prod Res (2012) 0.80

Synergistic interaction between baclofen administration into the median raphe nucleus and inconsequential visual stimuli on investigatory behavior of rats. Psychopharmacology (Berl) (2011) 0.79

Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism. Neuroimage (2012) 0.78

Clinical decision support improves quality of telephone triage documentation--an analysis of triage documentation before and after computerized clinical decision support. BMC Med Inform Decis Mak (2014) 0.75